NCT07304154 2026-03-10
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Gilead Sciences
Phase 1 Not yet recruiting
Clinical Trials
1 trialsNot yet recruiting × Polyradiculoneuropathy, Chronic Inflammatory Demyelinating × 30 days × Clear all